Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression

BACKGROUND: Prostate cancer (PCa) is the most commonly diagnosed solid tumor and the second leading cancer death in the United States, and also one of the major cancer-related deaths in Chinese. Androgen deprivation therapy (ADT) is the first line treatment for metastatic PCa. PCa ultimately relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Yu-Wei, Lin, Fen-Fen, Muniyan, Sakthivel, Lin, Frank C, Chen, Ching-Shih, Wang, Jue, Huang, Chao-Cheng, Lin, Ming-Fong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504398/
https://www.ncbi.nlm.nih.gov/pubmed/26185616
http://dx.doi.org/10.1186/s13578-015-0033-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504398/
https://www.ncbi.nlm.nih.gov/pubmed/26185616
http://dx.doi.org/10.1186/s13578-015-0033-y

Ejemplares similares